You are here

Article metrics

Article menu

Download PDFPDF

Research Article
Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy

 

Online download statistics by month:

Online download statistics by month: December 2019 to September 2025

AbstractFullPdf
Dec 2019110
Jan 2020552
Feb 202016165
Mar 202022227
Apr 202032328
May 202041413
Jun 202032324
Jul 202025258
Aug 202024243
Sep 202059599
Oct 2020747413
Nov 2020515110
Dec 202041416
Jan 202137378
Feb 202136368
Mar 2021494910
Apr 2021434317
May 2021373713
Jun 202111411415
Jul 2021292910
Aug 202140409
Sep 202148488
Oct 2021747420
Nov 2021585821
Dec 202139397
Jan 2022556014
Feb 202244469
Mar 2022747923
Apr 20229610624
May 20229910212
Jun 20229710018
Jul 20229910633
Aug 202210311233
Sep 2022909118
Oct 202210310933
Nov 202213113437
Dec 202211611617
Jan 202314214622
Feb 202312913429
Mar 2023808122
Apr 2023777834
May 202310710933
Jun 202310010731
Jul 2023868717
Aug 202310410417
Sep 202311311429
Oct 2023737514
Nov 2023858932
Dec 2023808015
Jan 2024434413
Feb 2024707120
Mar 202412612634
Apr 202411611629
May 2024767625
Jun 2024999921
Jul 202413914335
Aug 202410711123
Sep 20249810120
Oct 202411311435
Nov 2024878928
Dec 202416416729
Jan 202512712757
Feb 202521021030
Mar 202511811927
Apr 202513713831
May 2025858630
Jun 2025818121
Jul 2025220
Sep 2025220
Total531054141298